Omalizumab plus rush immunotherapy (RIT) is more effective than RIT alone in preventing ragweed-induced seasonal allergic rhinitis (SAR) symptoms
Year: 2005
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Language: English
Subfield: Immunology and Allergy
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2057415117
